HomeTWST • NASDAQ
add
Twist Bioscience Corp
Previous close
$45.52
Day range
$44.79 - $46.56
Year range
$15.86 - $60.90
Market cap
2.66B USD
Avg Volume
594.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 81.46M | 27.81% |
Operating expense | 79.26M | 12.29% |
Net income | -85.57M | -49.09% |
Net profit margin | -105.04 | -16.65% |
Earnings per share | -0.70 | 31.23% |
EBITDA | -35.69M | 11.22% |
Effective tax rate | -0.22% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 289.42M | -18.96% |
Total assets | 638.12M | -21.25% |
Total liabilities | 146.98M | -3.80% |
Total equity | 491.14M | — |
Shares outstanding | 58.59M | — |
Price to book | 5.43 | — |
Return on assets | -16.40% | — |
Return on capital | -17.91% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -85.57M | -49.09% |
Cash from operations | -6.38M | 72.76% |
Cash from investing | -711.00K | -103.81% |
Cash from financing | 2.91M | 539.94% |
Net change in cash | -4.18M | 26.98% |
Free cash flow | 6.02M | 464.11% |
About
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Founded
2013
Website
Employees
919
